These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2976977)

  • 1. Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis.
    Sørensen SS; Danielsen H; Pedersen EB
    Scand J Clin Lab Invest; 1988 Jun; 48(4):347-55. PubMed ID: 2976977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide and exaggerated natriuresis during acute hypertonic volume expansion in essential hypertension.
    Sørensen SS; Danielsen H; Amdisen A; Pedersen EB
    J Hypertens; 1989 Jan; 7(1):21-9. PubMed ID: 2523419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration.
    Jespersen B; Danielsen H; Pedersen EB
    Nephrol Dial Transplant; 1990; 5(12):997-1006. PubMed ID: 1965738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide, angiotensin II and aldosterone in plasma in chronic glomerulonephritis during basal conditions and during exercise.
    Danielsen H; Pedersen EB
    Acta Med Scand; 1988; 224(1):61-7. PubMed ID: 2970768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in renal tubular sodium and water handling during progression of polycystic kidney disease: relationship to atrial natriuretic peptide.
    Sørensen SS; Glud TK; Sørensen PJ; Amdisen A; Pedersen EB
    Nephrol Dial Transplant; 1990; 5(4):247-57. PubMed ID: 2141389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor, angiotensin II, aldosterone, arginine vasopressin and urinary prostaglandin E2 excretion in hyperfiltrating unilaterally nephrectomized humans.
    Sørensen SS; Jespersen B; Pedersen EB
    Scand J Clin Lab Invest; 1990 Jun; 50(4):371-8. PubMed ID: 2144053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B; Sørensen SS; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
    Graffe CC; Bech JN; Lauridsen TG; Pedersen EB
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F917-27. PubMed ID: 22262484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal haemodynamic changes, renal tubular function, sodium and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids.
    Tietze IN; Pedersen EB
    Nephrol Dial Transplant; 1994; 9(5):499-504. PubMed ID: 8090330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
    Graffe CC; Bech JN; Lauridsen TG; Vase H; Pedersen EB
    BMC Nephrol; 2012 Mar; 13():15. PubMed ID: 22452789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome.
    Tulassay T; Rascher W; Lang RE; Seyberth HW; Schärer K
    Kidney Int; 1987 Jun; 31(6):1391-5. PubMed ID: 2956451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exaggerated natriuresis in adult polycystic kidney disease.
    Danielsen H; Nielsen AH; Pedersen EB; Herlevsen P; Kornerup HJ; Posborg V
    Acta Med Scand; 1986; 219(1):59-66. PubMed ID: 3953317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects.
    Nielsen CB; Pedersen EB
    J Intern Med; 1994 Apr; 235(4):359-65. PubMed ID: 8151269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide and renal adaptation to contralateral nephrectomy in healthy man.
    Kamper AL; Pedersen EB; Strandgaard S; Holstein-Rathlou NH; Leyssac PP; Skaarup P; Hemmingsen L; Holm J; Munck O
    Scand J Clin Lab Invest; 1991 Feb; 51(1):99-103. PubMed ID: 1826969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal interaction of atrial natriuretic peptide with angiotensin II: glomerular and tubular effects.
    Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
    Clin Exp Pharmacol Physiol; 1989 Feb; 16(2):97-107. PubMed ID: 2523767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.